Invention Grant
- Patent Title: α-oxoacyl amino-caprolactam
- Patent Title (中): α-氧代酰基氨基 - 己内酰胺
-
Application No.: US14898249Application Date: 2014-06-13
-
Publication No.: US09562042B2Publication Date: 2017-02-07
- Inventor: Nobuo Kobayashi , Tsuneo Koji , Hisatomo Kunii , Mizuho Ishikawa , Daisuke Morita
- Applicant: Seikagaku Corporation
- Applicant Address: JP Tokyo
- Assignee: Seikagaku Corporation
- Current Assignee: Seikagaku Corporation
- Current Assignee Address: JP Tokyo
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Peter F. Corless; Christopher R. Cowles
- Priority: JP2013-125202 20130614
- International Application: PCT/JP2014/003160 WO 20140613
- International Announcement: WO2014/199645 WO 20141218
- Main IPC: C07D417/12
- IPC: C07D417/12 ; C07D223/12 ; C07D405/12 ; A61K31/55
Abstract:
The purpose of the present invention is to provide a pharmaceutical composition that is useful for the treatment of diseases that are caused by an increase in bone resorption and that does not cause serious side effects even when used in combination with another drug. The present invention relates to: an α-oxoacyl amino-caprolactam that is represented by formula (I) (in formula (I), X represents N or CH, Y represents O or CH2, and Z represents S or CH2); and a bone resorption inhibitor containing the α-oxoacyl amino-caprolactam.
Public/Granted literature
- US20160130266A1 ALPHA-OXOACYL AMINO-CAPROLACTAM BODY Public/Granted day:2016-05-12
Information query
